Listar por tema "rifampicin"

Ordenar por:Orden:Resultados:

  • Bartonella bacilliformis: A Systematic Review of the Literature to Guide the Research Agenda for Elimination 
    Sanchez Clemente, N.; Ugarte Gil, Cesar Augusto; Solórzano, N.; Maguiña Vargas, Ciro; Pachas, P.; Blazes, D.; Bailey, R.; Mabey, D.; Moore, David Alexander James (Public Library of Science, 2012)
    Background: Carrion's disease affects small Andean communities in Peru, Colombia and Ecuador and is characterized by two distinct disease manifestations: an abrupt acute bacteraemic illness (Oroya fever) and an indolent ...
  • Description of Bartonella ancashensis sp. nov., isolated from the blood of two patients with verruga peruana 
    Mullins, K.E.; Hang, J.; Jiang, J.; Leguia, M.; Kasper, M.R.; Ventosilla, P.; Maguiña Vargas, Ciro; Jarman, R.G.; Blazes, D.; Richards, A.L. (Microbiology Society, 2015)
    Three novel isolates of the genus Bartonella were recovered from the blood of two patients enrolled in a clinical trial for the treatment of chronic stage Bartonella bacilliformis infection (verruga peruana) in Caraz, ...
  • Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries 
    Ballif, M.; Nhandu, V.; Wood, R.; Dusingize, J.C.; Carter, E.J.; Cortes, C.P.; McGowan, C.C.; Diero, L.; Graber, C.; Renner, L.; Hawerlander, D.; Kiertiburanakul, S.; Du, Q.T.; Sterling, T.R.; Egger, M.; Fenner, L.; Ajayi, S.; Anastos, K.; Bashi, J.; Bishai, W.; Boulle, A.; Braitstein, P.; Carriquiry, G.; Carter, J.E.; Cegielski, P.; Chimbetete, C.; Conrad, J.; Davies, M.-A.; Duda, S.; Durier, N.; Eboua, T.F.; Gasser, A.; Geng, E.; Hardwicke, L.; Hoffmann, C.; Huebner, R.; Kancheya, N.; Kim, P.; Lameck, D.; Leroy, V.; Lewden, C.; Lindegren, M.L.; Mandalakas, A.; Maskew, M.; McKaig, R.; Mofenson, L.; Mpoudi-Etame, M.; Okwara, B.; Phiri, S.; Prasitsuebsai, W.; Petit, A.; Prozesky, H.; Reid, S.E.; Reubenson, G.; Sohn, A.; Vo, Q.; Walker, D.; Wehbe, F.; Wejse, C.; Wester, W.; Williams, C.; Wools-Kaloustian, K.; Yao, Z.; Yunihastuti, E.; Zhang, F.J.; Zhao, H.X.; Han, N.; Merati, T.P.; Wirawan, D.N.; Yuliana, F.; Ditangco, R.; Uy, E.; Bantique, R.; Phanuphak, P.; Ruxrungtham, K.; Avihingsanon, A.; Mengthaisong, T.; Sungkanuparph, S.; Sanmeema, N.; Chaiwarith, R.; Sirisanthana, T.; Kotarathititum, W.; Pham, T.T.; Cuong, D.D.; Ha, H.L.; Nguyen, V.K.; Bui, V.H.; Cao, T.T.; Sohn, A.H.; Petersen, B.; Cooper, D.A.; Law, M.G.; Jiamsakul, A.; Boettiger, D.C.; Wati, D.K.; Atmikasari, L.P.P.; Malino, I.Y.; Nallusamy, R.; Chan, K.C.; Lumbiganon, P.; Kosalaraksa, P.; Tharnprisan, P.; Udomphanit, T.; Chokephaibulkit, K.; Lapphra, K.; Phongsamart, W.; Wittawatmongkol, O.; Dung, K.T.K.; Lam, N.V.; An, P.N.; Loan, N.T.; Truong, H.K.; Du, T.Q.; Chau, N.H.; Do, C.V.; Ha, M.T.; Nipathakosol, P.; Kariminia, A.; Mutimura, E.; Gitembagara, A.; Tatwangire, J.; Izabelle, I.; Niyongabo, T.; Twizere, C.; Baramperanye, E.; Edmonds, A.; Yotebieng, M.; Azinyue, I.; Ayangma, L.; Yiannoutsos, C.; Ayaya, S.; Bukusi, E.A.; Lewis-Kulzer, J.; Somi, G.; Lyamuya, R.; Ngonyani, K.; Ssali, J.; Ssemuwemba, H.; Mwebesa, B.B.; Kambugu, A.; Hermans, S.; Nalugoda, F.; Jjingo, K.; Dickinsonn, D.; Eley, B.; Fritz, C.; Garone, D.; Giddy, J.; MacPhail, P.; Moultrie, H.; Ndirangu, J.; Pestilli, S.; Rabie, H.; Stringer, J.; Technau, K.; Kaeser, F.; Keiser, O.; Cornell, M.; Maxwell, N.; Zannou, D.M.; Ahouada, C.; Akakpo, J.; Ahomadegbé, C.; Gougounon-Houéto, A.; Azon-Kouanou, A.; Houngbé, F.; Sehonou, J.; Koumakpaï, S.; Alihonou, F.; D'Almeida, M.; Hodonou, I.; Hounhoui, G.; Sagbo, G.; Tossa-Bagnan, L.; Adjide, H.; Drabo, J.; Bognounou, R.; Dienderé, A.; Traore, E.; Zoungrana, L.; Zerbo, B.; Sawadogo, A.B.; Zoungrana, J.; Héma, A.; Soré, I.; Bado, G.; Tapsoba, A.; Yé, D.; Kouéta, F.; Ouedraogo, S.; Ouédraogo, R.; Hiembo, W.; Gansonré, M.; Messou, E.; Gnokoro, J.C.; Koné, M.; Kouakou, G.M.; Bosse, C.A.; Brou, K.; Assi, A.I.; Chenal, H.; Soppi, F.; Minga, A.; Abo, Y.; Eholié, S.P.; Amego, M.D.N.; Andavi, V.; Diallo, Z.; Ello, F.; Tanon, A.K.; Koule, S.O.; Anzan, K.C.; Guehi, C.; Aka, E.A.; Issouf, K.L.; Kouakou, J.-C.; N'Gbeche, M.-S.; Pety, T.; Avit-Edi, D.; Kouakou, K.; Moh, M.; Yao, V.A.; Folquet, M.A.; Dainguy, M.-E.; Kouakou, C.; Méa-Assande, V.T.; Oka-Berete, G.; Zobo, N.; Acquah, P.; Kokora, M.-B.; Eboua, T.F.; Timité-Konan, M.; Diecket Ahoussou, L.; Assouan, J.K.; Sami, M.F.; Kouadio, S.; Goka, B.; Welbeck, J.; Sackey, A.; Owiafe, S.N.; Da Silva, Z.J.; Paulo, J.; Rodrigues, A.; Da Silva, D.; Medina, C.; Oliviera-Souto, I.; Østergaard, L.; Laursen, A.; Sodemann, M.; Aaby, P.; Fomsgaard, A.; Erikstrup, C.; Eugen-Olsen, J.; Maïga, M.Y.; Diakité, F.F.; Kalle, A.; Katile, D.; Traore, H.A.; Minta, D.; Cissé, T.; Dembelé, M.; Doumbia, M.; Fomba, M.; Kaya, A.S.; Traoré, A.M.; Traoré, H.; Toure, A.A.; Dicko, F.; Sylla, M.; Berthé, A.; Traoré, H.C.; Koïta, A.; Koné, N.; N'Diaye, C.; Coulibaly, S.T.; Traoré, M.; Traoré, N.; Charurat, M.; Alim, G.; Dapiap, S.; Igbinoba, F.; Benson, O.; Adebamowo, C.; James, J.; Obaseki; Osakede, P.; Olasode, J.; Seydi, M.; Sow, P.S.; Diop, B.; Manga, N.M.; Tine, J.M.; Bassabi, C.C.; Sy, H.S.; Ba, A.; Diagne, A.; Dior, H.; Faye, M.; Gueye, R.D.; Mbaye, A.D.; Patassi, A.; Kotosso, A.; Kariyare, B.G.; Gbadamassi, G.; Komi, A.; Mensah-Zukong, K.E.; Pakpame, P.; Koko Lawson-Evi, A.; Atakouma, Y.; Takassi, E.; Djeha, A.; Ephoévi-gah, A.; El-Hadj Djibril, S.; Dabis, F.; Bissagnene, E.; Arrivé, E.; Coffie, P.; Ekouevi, D.; Jaquet, A.; Sasco, A.J.; Amani, D.; Azani, J.-C.; Balestre, E.; Bessekon, S.; Bohossou, F.; Gilbert, C.; Karcher, S.; Gonsan, J.M.; Le Carrou, J.; Lenaud, S.; Nchot, C.; Malateste, K.; Yao, A.R.; Siloué, B.; Clouet, G.; Dosso, M.; Doring, A.; Kouakou, A.; Rabourdin, E.; Rivenc, J.; Anglaret, X.; Ba, B.; Essanin, J.B.; Ciaranello, A.; Datté, S.; Desmonde, S.; Elvis Diby, J.-S.; Gottlieb, G.S.; Horo, A.G.; Kangah, S.N.; Malvy, D.; Meless, D.; Mounkaila-Harouna, A.; Ndondoki, C.; Shiboski, C.; Tchounga, B.; Thiébaut, R.; Wandeler, G.; McGowan, C.; Cahn, P.; Gotuzzo Herencia, José Eduardo; Wolff, M.; Grinsztejn, B.; Pape, J.; Padgett, D.; Madero, J.S. (International Union Against Tuberculosis and Lung Disease, 2014)
    SETTING: Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons. OBJECTIVE: To describe practices in the prevention and management of drug-resistant TB ...
  • A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. 
    Carriquiry, Gabriela; Otero Vegas, Larissa; González Lagos, Elsa Violeta; Zamudio Fuertes, Carlos Eduardo; Sánchez, Eduardo; Nabeta, Pamela; Campos, Miguel; Echevarria Zarate, Juan Ignacio; Seas Ramos, Carlos Rafael; Gotuzzo Herencia, José Eduardo (Public Library of Science, 2012)
    Background: Diagnosis of pulmonary tuberculosis (TB) among human immunodeficiency virus (HIV) patients remains complex and demands easy to perform and accurate tests. Xpert®MTB/RIF (MTB/RIF) is a molecular TB diagnostic ...
  • Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents 
    Torres-Romero, D.; Jiménez, I.A.; Rojas, R.; Gilman, Robert Hugh; López, M.; Bazzocchi, I.L. (Elsevier, 2011)
    In the present study, we report four new dihydro-β-agarofuran sesquiterpenes (1-4), which were isolated from the leaves of Celastrus vulcanicola, in addition to five derivatives (5-9). Their stereostructures were elucidated ...
  • Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study 
    Zürcher, K.; Ballif, M.; Fenner, L.; Borrell, S.; Keller, P.M.; Gnokoro, J.; Marcy, O.; Yotebieng, M.; Diero, L.; Carter, E.J.; Rockwood, N.; Wilkinson, R.J.; Cox, H.; Ezati, N.; Abimiku, A.G.; Collantes, J.; Avihingsanon, A.; Kawkitinarong, K.; Reinhard, M.; Hömke, R.; Huebner, R.; Gagneux, S.; Böttger, E.C.; Egger, M.; Chammartin, F.; Boettger, E.C.; Keller, P.; Abimiku, A.; Wenzi, L.; Tabala, M.; Warren, R.; Streicher, E.; Wilkinson, R.J.; Carter, E.J.; Zamudio Fuertes, Carlos Eduardo; Sohn, A.; Petersen, T.; Kasipong, N.; N'Guessan, K.; International epidemiology Databases to Evaluate AIDS (Elsevier, 2019)
    Background: Drug resistance is a challenge for the global control of tuberculosis. We examined mortality in patients with tuberculosis from high-burden countries, according to concordance or discordance of results from ...
  • High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors. 
    Otero Vegas, Larissa; Krapp, Fiorella; Tomatis, Cristina; Zamudio Fuertes, Carlos Eduardo; Matthys, Francine; Gotuzzo Herencia, José Eduardo; Van der Stuyft, Patrick; Seas Ramos, Carlos Rafael (Public Library of Science, 2011)
    Introduction: In high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR. However, this approach might miss ...
  • HIV-related tuberculosis: Mortality risk in persons without vs With culture-confirmed disease 
    Crabtree-Ramírez, B.; Jenkins, C.; Jayathilake, K.; Carriquiry, G.; Veloso, V.; Padgett, D.; Gotuzzo Herencia, José Eduardo; Cortes, C.; Mejía Cordero, Fernando Alonso; McGowan, C.C.; Duda, S.; Shepherd, B.E.; Sterling, T.R. (International Union Against Tuberculosis and Lung Disease, 2019)
    BACKGROUND: Tuberculosis (TB) diagnosis in human immunodeficiency virus (HIV) positive persons is difficult, particularly in resource-limited settings. The relationship between TB culture status and mortality in HIV-positive ...
  • Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid 
    Requena-Méndez, A.; Davies, G.; Waterhouse, D.; Ardrey, A.; Jave, O.; López-Romero, S.L.; Ward, S.A.; Moore, David Alexander James (Oxford University Press, 2018)
    Background: Poor response to TB therapy might be attributable to subtherapeutic levels in drug-compliant patients. Pharmacokinetic parameters can be affected by comorbidities or the interaction of drugs with food. Objectives ...
  • Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program 
    Clouse, K.; Blevins, M.; Lindegren, M.L.; Yotebieng, M.; Nguyen, D.T.; Omondi, A.; Michael, D.; Zannou, D.M.; Carriquiry, G.; Pettit, A.; IeDEA; Gotuzzo Herencia, José Eduardo; Mejía Cordero, Fernando Alonso; Carriquiry, G. (Public Library of Science, 2017)
    Objective: Xpert MTB/RIF is recommended by the World Health Organization (WHO) as the initial tuberculosis (TB) diagnostic test in individuals suspected of HIV-associated TB. We sought to evaluate field implementation of ...
  • MODS-Wayne, a colorimetric adaptation of the Microscopic-Observation Drug Susceptibility (MODS) assay for detection of mycobacterium tuberculosis pyrazinamide resistance from sputum samples 
    Alcántara, Roberto; Fuentes, Patricia; Antiparra, Ricardo; Santos, Marco; Gilman, Robert Hugh; Kirwan, Daniela E.; Zimic-Peralta, Mirko Juan; Sheen Cortavarria, Patricia (American Society for Microbiology, 2018)
    Although pyrazinamide (PZA) is a key component of first and second line tuberculosis treatment regimens, there is no gold standard to determine PZA resistance. Approximately 50% of multidrug-resistant tuberculosis (MDR-TB) ...
  • Molecular typing of "Candidatus bartonella ancashi," A new human pathogen causing Verruga Peruana 
    Mullins, Kristin E.; Hang, Jun; Jiang, Ju; Leguia, Mariana; Kasper, Matthew R.; Maguiña Vargas, Ciro; Jarman, Richard G.; Blazes, David L.; Richards, Allen L. (American Society for Microbiology, 2013)
    A recently described clinical isolate, “Candidatus Bartonella ancashi,” was obtained from a blood sample of a patient presenting with verruga peruana in the Ancash region of Peru. This sample and a second isolate obtained ...
  • Multidrug-resistant tuberculosis and culture conversion with bedaquiline 
    Diacon, Andreas H.; Pym, Alexander; Grobusch, Martin P.; De Los Rios, Jorge M.; Gotuzzo Herencia, José Eduardo; Vasilyeva, Irina; Leimane, Vaira; Andries, Koen; Bakare, Nyasha; De Marez, Tine; Haxaire-Theeuwes, Myriam; Lounis, Nacer; Meyvisch, Paul; De Paepe, Els; Van Heeswijk, Rolf P.G.; Dannemann, Brian (Massachusetts Medical Society, 2014)
    BACKGROUND: Bedaquiline (Sirturo, TMC207), a diarylquinoline that inhibits mycobacterial ATP synthase, has been associated with accelerated sputum-culture conversion in patients with multidrug-resistant tuberculosis, when ...
  • Predominant Mycobacterium tuberculosis families and high rates of recent transmission among new cases are not associated with primary multidrug resistance in Lima, Peru 
    Barletta, F.; Otero Vegas, Larissa; de Jong, B.C.; Iwamoto, T.; Arikawa, K.; Van der Stuyft, P.; Niemann, S.; Merker, M.; Uwizeye, C.; Seas Ramos, Carlos Rafael; Rigouts, L. (American Society for Microbiology, 2015)
    Sputum samples from new tuberculosis (TB) cases were collected over 2 years as part of a prospective study in the northeastern part of Lima, Peru. To measure the contribution of recent transmission to the high rates of ...
  • Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: A cost-effectiveness analysis 
    Vassall, A.; van Kampen, S.; Sohn, H.; Michael, J.S.; John, K.R.; den Boon, S.; Davis, J.L.; Whitelaw, A.; Nicol, M.P.; Gler, M.T.; Khaliqov, A.; Zamudio Fuertes, Carlos Eduardo; Perkins, M.D.; Boehme, C.C.; Cobelens, F. (Public Library of Science, 2011)
    Background: Xpert MTB/RIF (Xpert) is a promising new rapid diagnostic technology for tuberculosis (TB) that has characteristics that suggest large-scale roll-out. However, because the test is expensive, there are concerns ...
  • Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014 
    Cornejo Garcia, Jose Gabriel; Alarcón Guizado, Valentina Antonieta; Mendoza Ticona, Alberto; Alarcon, Edith; Heldal, Einar; Moore, David Alexander James (Public Library of Science, 2018)
    Background: Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing—the widely ...
  • Tuberculous Meningitis: Impact of Timing of Treatment Initiation on Mortality 
    Soria, J.; Chiappe, A.; Gallardo, J.; Zunt, J.R.; Lescano Guevara, Andres Guillermo (Oxford University Press, 2021)
    We conducted a retrospective cross-sectional study of adult hospitalized patients with confirmed tuberculous meningitis to determine the impact of the timing of treatment initiation on mortality. The mortality of tuberculous ...

Buscar en el Repositorio

Listar

Panel de Control